1. Home
  2. VYX vs VCEL Comparison

VYX vs VCEL Comparison

Compare VYX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYX
  • VCEL
  • Stock Information
  • Founded
  • VYX 1881
  • VCEL 1989
  • Country
  • VYX United States
  • VCEL United States
  • Employees
  • VYX N/A
  • VCEL N/A
  • Industry
  • VYX
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VYX
  • VCEL Health Care
  • Exchange
  • VYX Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • VYX 1.8B
  • VCEL 2.1B
  • IPO Year
  • VYX N/A
  • VCEL 1997
  • Fundamental
  • Price
  • VYX $13.31
  • VCEL $34.05
  • Analyst Decision
  • VYX Strong Buy
  • VCEL Strong Buy
  • Analyst Count
  • VYX 5
  • VCEL 6
  • Target Price
  • VYX $14.20
  • VCEL $61.50
  • AVG Volume (30 Days)
  • VYX 1.5M
  • VCEL 565.9K
  • Earning Date
  • VYX 08-07-2025
  • VCEL 07-31-2025
  • Dividend Yield
  • VYX N/A
  • VCEL N/A
  • EPS Growth
  • VYX N/A
  • VCEL 2045.40
  • EPS
  • VYX 7.32
  • VCEL 0.13
  • Revenue
  • VYX $2,677,000,000.00
  • VCEL $249,119,000.00
  • Revenue This Year
  • VYX N/A
  • VCEL $18.35
  • Revenue Next Year
  • VYX N/A
  • VCEL $22.47
  • P/E Ratio
  • VYX $1.81
  • VCEL $256.98
  • Revenue Growth
  • VYX N/A
  • VCEL 16.13
  • 52 Week Low
  • VYX $7.55
  • VCEL $33.09
  • 52 Week High
  • VYX $15.34
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • VYX 53.76
  • VCEL 40.14
  • Support Level
  • VYX $12.49
  • VCEL $33.34
  • Resistance Level
  • VYX $13.77
  • VCEL $36.81
  • Average True Range (ATR)
  • VYX 0.41
  • VCEL 1.36
  • MACD
  • VYX -0.01
  • VCEL -0.13
  • Stochastic Oscillator
  • VYX 66.23
  • VCEL 20.14

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: